Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting Approximately 83% of children treated with ...

When outcome selection and prioritisation are defined early in development, the evidence base supports continuity from trial ...

A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...

Belzutifan-lenvatinib slows progression versus cabozantinib with much longer response dura ...

The bispecific ADC izalontamab brengitecan improved survival for patients with metastatic triple-negative breast cancer in a ...

Overview:  Network security has become a strategic priority as organizations face AI-driven cyberattacks, ransomware-as-a-service, and sophisticated zero-d ...

Zero Trust isn't magic. It's a specific set of architectural components working together—policy engine, identity fabric, device trust, microsegmentation, and continuous monitoring. Here's exactly how ...

AI rattled cybersecurity markets after Anthropic launched Claude Code Security. Here’s what actually changed, what didn’t and how leaders should respond.

Investors are running for the exits on cybersecurity stocks as persistent artificial intelligence disruption fears overpower ...

The 59.4% real-world pain responder rate from the use of inFoods® IBS closely mirrors the 59.6% result from the controlled trial-offering an unusual degree of consistency between controlled and ...

Q4 2025 earnings call: ivonescimab Phase III updates, FDA PDUFA timeline, interim PFS in Q2 2026, cash position—read now.

Every device that touches the internet leaves tiny digital breadcrumbs behind. Chief among them is the IP address, a string of numbers that acts like the mailing label of your connection. With a ...